WebPULM 1W Swing Edition test Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based test Pulmatrix, Inc. is a … WebFeb 6, 2024 · PULM Stock Message Board for Investors. Pulmatrix, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 35
PULM -- Is Its Stock Price A Worthy Investment? Learn More.
WebApr 14, 2024 · PULM opened at $2.77 on Friday. Pulmatrix has a 12-month low of $2.70 and a 12-month high of $7.50. The business’s fifty day simple moving average is $3.30 and its 200-day simple moving average ... WebPULM has a higher average analyst price target than 111.96% of Pharmaceutical Products stocks. In the context of stocks in the micro market cap category, PULMATRIX INC's upside potential (average analyst target price relative to current price) is higher than 165.38% of them. In terms of price targets and recommendations offered by analysts, the ... la baraka definition
Pulmatrix Inc (PULM) Stock Price Today, News, Quotes, FAQs and …
WebPulmatrix Announces Year-End and Q4 Financial 2024 Results and Provides Corporate Update. Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company … WebA physician-scientist (80-90% research, 10-20% ICU/Pulm Clinic/Teaching), a Clinician-Investigator (~60% research 40% ICU/Pulm/etc), and an academic clinician (10/90% split the other way). Interestingly enough, although there are lots of compensation models, many programs base your "worth" to them on academic output, regardless of which track you … Web2 days ago · Analyst Forecast. According to 7 analysts, the average rating for PULM stock is "Buy." The 12-month stock price forecast is $10.2, which is an increase of 262.99% from the latest price. la baraka little neck menu